Literature DB >> 9769337

Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.

R Wessely1, K Klingel, L F Santana, N Dalton, M Hongo, W Jonathan Lederer, R Kandolf, K U Knowlton.   

Abstract

Numerous studies have implicated Coxsackievirus in acute and chronic heart failure. Although enteroviral nucleic acids have been detected in selected patients with dilated cardiomyopathy, the significance of such persistent nucleic acids is unknown. To investigate the mechanisms by which restricted viral replication with low level expression of Coxsackieviral proteins may be able to induce cardiomyopathy, we generated transgenic mice which express a replication-restricted full-length Coxsackievirus B3 (CVB3) cDNA mutant (CVB3DeltaVP0) in the heart driven by the cardiac myocyte-specific myosin light chain-2v (MLC-2v) promoter. CVB3DeltaVP0 was generated by mutating infectious CVB3 cDNA at the VP4/VP2 autocatalytic cleavage site from Asn-Ser to Lys-Ala. Cardiac-specific expression of this cDNA leads to synthesis of positive- and negative-strand viral RNA in the heart without formation of infectious viral progeny. Histopathologic analysis of transgenic hearts revealed typical morphologic features of myocardial interstitial fibrosis and in some cases degeneration of myocytes, thus resembling dilated cardiomyopathy in humans. There was also an increase in ventricular atrial natriuretic factor mRNA levels, demonstrating activation of the embryonic program of gene expression typical of ventricular hypertrophy and failure. Echocardiographic analysis demonstrated the presence of left ventricular dilation and decreased systolic function in the transgenic mice compared with wild-type littermates, evidenced by increased ventricular end-diastolic and end-systolic dimensions and decreased fractional shortening. Analysis of isolated myocytes from transgenic mice demonstrate that there is defective excitation-contraction coupling and a decrease in the magnitude of isolated cell shortening. These data demonstrate that restricted replication of enteroviral genomes in the heart can induce dilated cardiomyopathy with excitation-contraction coupling abnormalities similar to pressure overload models of dilated cardiomyopathy.

Entities:  

Mesh:

Year:  1998        PMID: 9769337      PMCID: PMC508992          DOI: 10.1172/JCI1972

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report--1996.

Authors:  J D Hosenpud; R J Novick; L E Bennett; B M Keck; B Fiol; O P Daily
Journal:  J Heart Lung Transplant       Date:  1996-07       Impact factor: 10.247

2.  MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure.

Authors:  S Arber; J J Hunter; J Ross; M Hongo; G Sansig; J Borg; J C Perriard; K R Chien; P Caroni
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

3.  Ca2+ flux through promiscuous cardiac Na+ channels: slip-mode conductance.

Authors:  L F Santana; A M Gómez; W J Lederer
Journal:  Science       Date:  1998-02-13       Impact factor: 47.728

4.  Persistent infection of human lymphoid cells with poliovirus and development of temperature-sensitive mutants.

Authors:  R I Carp
Journal:  Intervirology       Date:  1981       Impact factor: 1.763

5.  Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes.

Authors:  L F Santana; E G Kranias; W J Lederer
Journal:  J Physiol       Date:  1997-08-15       Impact factor: 5.182

6.  Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice.

Authors:  K R Gottshall; J J Hunter; N Tanaka; N Dalton; K D Becker; J Ross; K R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure.

Authors:  A M Gómez; H H Valdivia; H Cheng; M R Lederer; L F Santana; M B Cannell; S A McCune; R A Altschuld; W J Lederer
Journal:  Science       Date:  1997-05-02       Impact factor: 47.728

8.  NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice.

Authors:  E M Schwarz; C Badorff; T S Hiura; R Wessely; A Badorff; I M Verma; K U Knowlton
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Transthoracic echocardiography in models of cardiac disease in the mouse.

Authors:  N Tanaka; N Dalton; L Mao; H A Rockman; K L Peterson; K R Gottshall; J J Hunter; K R Chien; J Ross
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

10.  Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon.

Authors:  R Kandolf; A Canu; P H Hofschneider
Journal:  J Mol Cell Cardiol       Date:  1985-02       Impact factor: 5.000

View more
  44 in total

Review 1.  Meeting Koch's postulates for calcium signaling in cardiac hypertrophy.

Authors:  K R Chien
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  Cellular and molecular basis of inflammatory myocardial disease.

Authors:  W H Barry
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

3.  Modulation of CICR has no maintained effect on systolic Ca2+: simultaneous measurements of sarcoplasmic reticulum and sarcolemmal Ca2+ fluxes in rat ventricular myocytes.

Authors:  A W Trafford; M E Díaz; G C Sibbring; D A Eisner
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

Review 4.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.

Authors:  Claudia T Flynn; Taishi Kimura; Kwesi Frimpong-Boateng; Stephanie Harkins; J Lindsay Whitton
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

Review 6.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice.

Authors:  Carola Leipner; Katja Grün; Ilka Schneider; Brigitte Glück; Holger H Sigusch; Axel Stelzner
Journal:  Med Microbiol Immunol       Date:  2003-10-31       Impact factor: 3.402

Review 8.  [Molecular mechanisms and consequences of cardiac viral infections].

Authors:  R Kandolf; B Bültmann; K Klingel; C-T Bock
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

Review 9.  Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?

Authors:  M Pauschinger; M Noutsias; D Lassner; H-P Schultheiss; U Kuehl
Journal:  Clin Res Cardiol       Date:  2006-08-16       Impact factor: 5.460

Review 10.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.